Literature DB >> 14760227

[Misuse of tianeptine: five cases of abuse].

Loïc Leterme1, Yves-Stéphane Singlan, Valérie Auclair, Reynald Le Boisselier, Vincent Frimas.   

Abstract

Five cases of excessive consumption of tianeptine suggest possible drug-abuse of this substance. This side effect is unknown in animals and humans. According to DSM IV, CIM 10 criteria and the French public health code, these five patients had pathological profiles of psychoactive drug abusers. Tianeptine dosage was always used higher than recommended and the drug was taken in association with other psychotropes. Withdrawal was difficult and induced anxiety and other disorders which led to relapse in most of the patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14760227

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN: 0003-410X


  4 in total

1.  Acute Toxicity From Intravenous Use of the Tricyclic Antidepressant Tianeptine.

Authors:  Sara K Dempsey; Justin L Poklis; Kacie Sweat; Kirk Cumpston; Carl E Wolf
Journal:  J Anal Toxicol       Date:  2017-07-01       Impact factor: 3.367

2.  The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor.

Authors:  Benjamin Adam Samuels; Katherine M Nautiyal; Andrew C Kruegel; Marjorie R Levinstein; Valerie M Magalong; Madalee M Gassaway; Steven G Grinnell; Jaena Han; Michael A Ansonoff; John E Pintar; Jonathan A Javitch; Dalibor Sames; René Hen
Journal:  Neuropsychopharmacology       Date:  2017-03-17       Impact factor: 7.853

Review 3.  Abuse and misuse of antidepressants.

Authors:  Elizabeth A Evans; Maria A Sullivan
Journal:  Subst Abuse Rehabil       Date:  2014-08-14

Review 4.  Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network.

Authors:  Thomas Soeiro; Clémence Lacroix; Vincent Pradel; Maryse Lapeyre-Mestre; Joëlle Micallef
Journal:  Front Psychiatry       Date:  2021-05-17       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.